Skip to content
RNAC Cartesian Therapeutics, Inc. Common Stock
$7.51 1.21% +0.09
Notify me if price changes either direction
Interactive Brokers Logotype

Buy RNAC stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 218.0M
Enterprise value 111.2M
Trailing PE 1.9756098
Forward PE -2.7686567
PEG Ratio 0.017223264923077
Enterprise to EBITDA -1.251
Enterprise to revenue 62.662
Price to book MRQ -1.3607256430009
Price to sales TTM 122.823006

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 1.8M
EBITDA -88897000
Diluted EPS TTM -5.8
Total Cash (MRQ) 118.6M
Current ratio (MRQ) 7.654
Operating Cash Flow (TTM) -72968000

RNAC trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent RNAC News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.

Crypto Growth Agency

Crypto Growth Agency

Since 2019, we've worked together with 250+ in the Crypto space.

Get started